COVID-19 Associated Mucormycosis::A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic

At a time when the COVID-19's second wave is still picking up in countries like India, a number of reports describe the potential association with a rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease

Should suppliers allow capacity transfers?

This research considers situations in which buyers pay to reserve their suppliers’ capacity for future use. The study specifically explores whether suppliers should provide transfer rights, allowing buyers unable to use all of their reserved capacity to transfer the excess to another buyer, and whether they should charge a transfer fee. The study finds that, in most cases, the supplier maximizes financial outcomes when the buyer releasing the excess capacity keeps most of the retail-level profit from the transfer and the supplier does not charge a transfer fee.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/172956/1/poms13687-sup-0001-OnlineAppendix.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/172956/2/poms13687.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/172956/3/poms13687_am.pd